Follow

Prostatype Genomics AB

Nasdaq First North GM (Sweden)

Prostatype Genomics manufactures, markets and sells the prognostic gene test Prostatype. By giving a assessment of the aggressiveness of the prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions.
Go to market

Sector:
HEALTH CARE
>
Health Care Equipment & Services
Healthcare
Exercise
Price
10.90 SEK
Exercise period(s)
27 Jan - 17 Feb 2022
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
PROGEN
SE0014684569
Nasdaq First North GM
Sweden (SE)
Details of share in Prostatype Genomics AB with ticker PROGEN
Status
Active
Amount of instruments
13 186 870
Currency
SEK
First trading date
03 Nov 2020
Type
Price
Pre-money
Time
Files
IPO
9.65 SEK
89.8M SEK
17 Sep - 01 Oct 2020
IPO in Prostatype Genomics AB
Type
Price
Pre-money
Time
Files
Directed issue
13.00 SEK
171.43M SEK
26 Aug - 27 Aug 2021
Share issue in Prostatype Genomics AB
Type
Ticker
ISIN
Market
OPTION
PROGEN TO 1
SE0014956462
Nasdaq First North GM
Sweden (SE)
Details of option in Prostatype Genomics AB with ticker PROGEN TO 1
Status
Active
Amount of instruments
3 885 320
Currency
SEK
Trading period
03 Nov 2020 - 15 Feb 2022
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 10.90 during the subscription period from January 27, 2022 until February 17, 2022.
Type
Price
Pre-money
Time
Files
Exercise
10.90 SEK
164.47M SEK
27 Jan - 17 Feb 2022
Option exercise terms for PROGEN TO 1
People
Fredrik Persson
CEO
Anders Lundberg
Chairman of the board
Michael Häggman
Board member
Karlheinz Schmelig
Board member
Håkan Englund
Board member
Christoph Petry
Board member
Company Details
Sector
HEALTH CARE

Address
Industrivägen 19
Zip code
171 48
City/district
Solna
Country
Sweden (SE)
Registration number
556726-0285
LEI code
549300JO6MPCGPVHVU91
First trade date
03 Nov 2020
Registration date
12 Mar 2007
Short name
Prostatype Genomics

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More